Oxeia Biopharmaceuticals

View Original

NB Science Cafe: Dr. Michael Wyand

Oxeia’s CEO, Dr. Michael Wyand,  spoke to a local Massachusetts audience, the NB Science Cafe, about "Clinical Trials for Concussion; A Critical Unmet Medical Need.”  The NB Science Cafe provides opportunities for members of the public to expand their scientific knowledge and have a dialog with scientists in an informal setting

Watch Here